Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Immune cell 'survival' gene key to better myeloma treatments

04.02.2013
Scientists have identified the gene essential for survival of antibody-producing cells, a finding that could lead to better treatments for diseases where these cells are out of control, such as myeloma and chronic immune disorders.

The discovery that a gene called Mcl-1 is critical for keeping this vital immune cell population alive was made by researchers at Melbourne's Walter and Eliza Hall Institute. Associate Professor David Tarlinton, Dr Victor Peperzak and Dr Ingela Vikstrom from the institute's Immunology division led the research, which was published today in Nature Immunology.

Antibody-producing cells, also known as plasma cells, live in the bone marrow and make antibodies that provide a person with long-term protection from viruses and bacteria, Associate Professor Tarlinton said. "Plasma cells are produced after vaccination or infection and are responsible for the immune 'memory' that can persist in humans for 70 or 80 years. In this study, we found that plasma cells critically rely on Mcl-1 for their continued survival and, without it, they die within two days," he said.

Dr Peperzak said the team was surprised to find that plasma cells used this as a 'failsafe' mechanism in controlling their survival. "One of the interesting things we found is that because plasma cells rapidly destroy Mcl-1 proteins within the cell yet depend on it for their survival, they need continuous external signals to tell them to produce more Mcl-1 protein," Dr Peperzak said. "This keeps the plasma cells under tight control, with Mcl-1 acting like a timer that constantly counts down and, if not reset, instructs the cell to die."

Plasma cells are vital to the immune response, but can be dangerous if not properly controlled, Associate Professor Tarlinton said. "As with any immune cell, plasma cells are really quite dangerous in many respects and need to be tightly controlled," he said. "When they are out of control they continue to make antibodies that can be very damaging if there are too many. This happens in conditions such as myeloma – a cancer of plasma cells – and various forms of autoimmunity, such as systemic lupus erythamatosus or rheumatoid arthritis, where there are excessive levels of antibodies."

Myeloma is a blood cancer that affects more than 1200 Australians each year, and is more common in people over 60. It is caused by the uncontrolled production of abnormal plasma cells in the bone marrow and the build up of damaging antibodies in the blood. Rheumatoid arthritis and lupus are autoimmune diseases in which the antibodies produced by plasma cells attack and destroy the body's own tissues.

Associate Professor Tarlinton said that his hope was that the discovery could be used to develop new treatments for these conditions. "Myeloma in particular has a very poor prognosis, and is generally considered incurable," Associate Professor Tarlinton said. "Now that we know Mcl-1 is the one essential gene needed to keep plasma cells alive, we have begun 'working backwards' to identify all the critical molecules and signals needed to switch on Mcl-1 and keep the cells alive. Our hope is that we will identify some point in the internal cell signalling pathway, or a critical external molecule, that could be blocked to stop Mcl-1 being produced by the cell. This would be an important new platform for diseases that currently have no specific or effective treatment, such as myeloma, or offer new treatment options for people who don't respond well to existing treatments for diseases such as lupus or rheumatoid arthritis."

This research was supported by the National Health and Medical Research Council of Australia, Multiple Myeloma Research Foundation, European Molecular Biology Organization and the Victorian Government.

Liz Williams | EurekAlert!
Further information:
http://www.wehi.edu.au

More articles from Life Sciences:

nachricht Common bacteria on verge of becoming antibiotic-resistant superbugs
26.03.2015 | Washington University School of Medicine

nachricht Chemical tag marks future microRNAs for processing, study shows
25.03.2015 | Rockefeller University

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neurochip für die Hirnforschung erfolgreich im Markt

Neues Mess- und Stimulationssystem nimmt die Kommunikation von Nervenzellen in Echtzeit auf und ermöglicht damit lang erhoffte Grundlagenforschung

Für die Enträtselung neurologischer und neurodegenerativer Erkrankungen wie Parkinson, Alzheimer, Depression oder verschiedene Erblindungsformen verspricht ein...

Im Focus: Klassisch oder nicht? Physik der Nanoplasmen

Die Wechselwirkung von intensiven Laserpulsen mit Partikeln auf einer Nanometer-Skala resultiert in der Erzeugung eines expandierenden Nanoplasmas.

In der Vergangenheit wurde die Dynamik eines Nanoplasmas typischerweise durch klassische Phänomene wie die thermische Emission von Elektronen beschrieben. Im...

Im Focus: Klimawandel: Nur auf der Erde, nicht auf dem Mars

Löcher in der Polkappe sind natürlichen Ursprungs

Eine Klimaerwärmung findet auf dem Mars trotz schmelzender Polkappen nicht statt. Zu diesem Ergebnis ist eine Studie der University of Arizona http://www.arizona.edu...

Im Focus: Experiment Provides the Best Look Yet at 'Warm Dense Matter' at Cores of Giant Planets

In an experiment at the Department of Energy's SLAC National Accelerator Laboratory, scientists precisely measured the temperature and structure of aluminum as...

Im Focus: Energieautark und kabellos: Neuartiges Messsystem schützt Schiffe vor Ausfällen

Wie der Schiffsverkehr zuverlässiger werden kann, während gleichzeitig der Instandhaltungsaufwand sinkt, zeigt das IPH bei der Hannover Messe 2015. Gemeinsam mit Projektpartnern hat das hannoversche Forschungsinstitut ein Sensorsystem entwickelt, das den Zustand von Schiffsgetrieben permanent überwacht und so Ausfällen vorbeugt. Das Besondere: Das Überwachungssystem funktioniert drahtlos und energieautark. Der benötigte Strom wird dort erzeugt, wo er gebraucht wird – direkt am Sensor.

Autos müssen regelmäßig zum TÜV, Schiffe müssen zur Inspektion – denn wenn mitten im Verkehr der Antrieb ausfällt, ist das nicht nur ärgerlich, sondern auch...

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Technologietag bei der SCHOTT AG - Neue Strukturierungstechnologien für Dünngläser

26.03.2015 | Veranstaltungen

7th Mildred Scheel Cancer Conference

26.03.2015 | Veranstaltungen

Corporate Venturing als Quelle unternehmerischer Innovationen

26.03.2015 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Künstliche Muskeln: Gelenkiger Spinnen-Greifer für Industrieroboter passt sich dem Werkstück an

26.03.2015 | HANNOVER MESSE

Technologietag bei der SCHOTT AG - Neue Strukturierungstechnologien für Dünngläser

26.03.2015 | Veranstaltungsnachrichten

Bislang bester Blick auf Staubwolke, die am Schwarzen Loch im Zentrum der Milchstraße vorbeizog

26.03.2015 | Physik Astronomie